Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Isoniazid (Nydrazid) and Rifabutin (Mycobutin) are both antibiotics, but they are used for different purposes and belong to different drug classes. Isoniazid is an antitubercular agent primarily used to treat and prevent tuberculosis (TB), while Rifabutin is a rifamycin antibiotic used to prevent Mycobacterium avium complex (MAC) infection in people with advanced HIV. Isoniazid is available in both oral and injectable forms, whereas Rifabutin is only available as an oral capsule. Isoniazid can cause serious liver injury and nerve problems, and it interacts with many foods and medications. Rifabutin, on the other hand, can change the color of your body fluids and skin, and it also interacts with many medications, including some HIV treatments. Both medications require careful monitoring by your healthcare provider.
Isoniazid
Rifabutin (Mycobutin)
Isoniazid
Rifabutin (Mycobutin)
Summary of Isoniazid vs. Mycobutin
Summary for Antimycobacterial agent
Prescription only
Isoniazid is an antimycobacterial agent for treating and preventing tuberculosis (TB) in children and adults. It's available as a generic oral tablet and solution, usually taken daily or a few times a week, depending on your dose. For treating active TB, you'll likely need to take it along with other TB medications (like rifampin, pyrazinamide, and ethambutol) to prevent antibiotic resistance. Serious side effects include severe liver injury. It's also known to interact with many foods and medications.
Summary for Rifamycin antibiotic
Prescription only
Rifabutin (Mycobutin) is used to prevent Mycobacterium avium complex (MAC) infection in people with advanced human immunodeficiency virus (HIV). It's available as a capsule that's taken by mouth, typically once daily. The most common side effect of rifabutin (Mycobutin) include temporarily change the color of your teeth, body fluids, and even urine.